Ajinomoto Co., Inc. 2802
TSE · Japan · Consumer Non-Durables
¥5,212.00-48.00 (-0.91%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
According to its website, Amoy distributes its products in “more than 40 countries”, including the US, Canada and the UK.
Opportunities span biosimilars, cell and gene therapy, diagnostics, vaccines and precision medicine, supported by AI protein design, flexible bioprocessing and regional manufacturing.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Recombinant Proteins Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report analyzes the global recombinant proteins market, projected to grow from USD 5.78 billion in 2026 to USD 11.42 billion by 2032 at a CAGR
Semiconductor manufacturing has brought some unlikely businesses into the spotlight.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.